Dr Emily K Staudenmaier, DO | |
1000 Montauk Hwy, West Islip, NY 11795-4927 | |
(631) 376-4163 | |
(631) 376-3420 |
Full Name | Dr Emily K Staudenmaier |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 7 Years |
Location | 1000 Montauk Hwy, West Islip, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255861423 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 287120 (Massachusetts) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Atrius Health Inc | 4789588641 | 1116 |
News Archive
Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who are not candidates for intensive high-dose chemotherapy.
People who need an operation will wait no more than 18 weeks by 2008, Health Secretary John Reid said today.
Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.
The insular cortex is an integral "hub", combining sensory, emotional and cognitive content. Not surprisingly, alterations in insular structure and function have been reported in many psychiatric disorders, such as anxiety disorders, depression, addiction and autism spectrum disorders (ASD).
› Verified 6 days ago
Entity Name | Atrius Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who are not candidates for intensive high-dose chemotherapy.
People who need an operation will wait no more than 18 weeks by 2008, Health Secretary John Reid said today.
Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.
The insular cortex is an integral "hub", combining sensory, emotional and cognitive content. Not surprisingly, alterations in insular structure and function have been reported in many psychiatric disorders, such as anxiety disorders, depression, addiction and autism spectrum disorders (ASD).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Emily K Staudenmaier, DO 230 Worcester St, Wellesley, MA 02481-5420 Ph: (781) 431-5429 | Dr Emily K Staudenmaier, DO 1000 Montauk Hwy, West Islip, NY 11795-4927 Ph: (631) 376-4163 |
News Archive
Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who are not candidates for intensive high-dose chemotherapy.
People who need an operation will wait no more than 18 weeks by 2008, Health Secretary John Reid said today.
Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.
The insular cortex is an integral "hub", combining sensory, emotional and cognitive content. Not surprisingly, alterations in insular structure and function have been reported in many psychiatric disorders, such as anxiety disorders, depression, addiction and autism spectrum disorders (ASD).
› Verified 6 days ago
Dr. John J Vullo, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 556 Montauk Hwy, West Islip, NY 11795 Phone: 631-321-4811 Fax: 631-321-4814 | |
Margarita Jurak, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 320 Montauk Hwy, South Bay Ob/gyn, P.c., West Islip, NY 11795 Phone: 631-587-2500 Fax: 631-587-0292 | |
Ms. Jacqueline A Ammirata, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 320 Montauk Highway, South Bay Ob Gyn Pc, West Islip, NY 11795 Phone: 631-587-2500 Fax: 631-587-0292 | |
Mr. Peter A Judge, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 320 Montauk Highway, South Bay Ob Gyn Pc, West Islip, NY 11795 Phone: 631-587-2500 Fax: 631-587-0292 | |
Angelica M Hernandez, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 320 Montauk Hwy, West Islip, NY 11795 Phone: 631-587-2500 Fax: 631-587-0292 | |
Richard J Klein, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 747 Montauk Hwy, West Islip, NY 11795 Phone: 631-587-4800 Fax: 631-587-4830 |